Mahima Datla (#1394)
- $ 3 B
- Vaccines
- India
- F
- 48 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Mahima Datla is the managing director of Biological E, a privately held vaccine producer, in which she holds a controlling stake. The Hyderabad-based company's portfolio includes Corbevax, a Covid-19 vaccine developed in partnership with Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston. Biological E has 10 vaccines pre-qualified by the World Health Organization including those against polio, tetanus and measles. It exports vaccines to more than 130 countries. Biological E was founded in 1953 by her paternal and maternal grandfathers. In July 2025 Bioligcal E struck a licensing agreement with China's Jiangsu Recbio Technology to manufacture and commercialize HPV vaccines to combat cancer.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Mahima Datla’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Mahima Datla’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $3.0B
(May 4, 2026)
© Iconic Billionaires